DOR BIOPHARMA INC

DOR

Insider trading at DOR BIOPHARMA INC

Transactions on record: 370; since Sep 18, 2003

Insider buys: 53; $24.2M

Insider sells: 32; $1.4M

Active insiders · 12 months: 4; last filing Dec 12, 2025

Figures computed from official regulatory filings — methodology.

Current insiders at DOR BIOPHARMA INC

ARIES DOMESTIC FUND II L P10% owner
ARIES DOMESTIC FUND L P10% owner
ARIES FINANCIAL SERVICES INC10% owner
ARIES SELECT II LLC10% owner
ARIES SELECT I LLC10% owner
ARIES SELECT LTD10% owner
ARIES TRUST10% owner
BAM Management LLC10% owner
Berman Ross10% owner
Biotex Pharma Investments, LLC10% owner
Brey Robert NChief Scientific Off., Sr. VP
Brownlie Keith LDirector
Brughera Marco MariaDirector
Buhrman Cyrille FDirector
CAVAZZA CLAUDIO10% owner
Cavazza EnricoFormer 10% Owner
Cavazza FrancescaFormer 10% Owner
CAVAZZA PAOLOFormer 10% Owner
CAVAZZA PAOLO10% owner
Cavazza Preta MartinaFormer 10% Owner
Cavazza SilviaFormer 10% Owner
Clavijo JamesController/Treasurer
Cote Timothy R.Director
Davenport GregoryPresident Biodefense Division
Donini OreolaCSO
ELAN CORP PLC10% owner
ELAN INTERNATIONAL SERVICES LTD10% owner
ELAN PHARMACEUTICAL INVESTMENTS II LTD10% owner
ELAN PHARMACEUTICAL INVESTMENTS LTD10% owner
ELLISON RALPHADirector
ELLISON RALPHACEO/President
Guarino Jonathan L.CFO
HAIG ALEXANDER M JR GENERAL USA RETDirector
Haig Alexander PDirector
Hamilton Brian LChief Medical Officer & Sr VP
HORGAN KEVINChief Medical Officer & Sr. VP
HOWSON TAMAR DDirector
INTREXON CORP10% owner
KANZER STEVE HDirector
KESSEL LARRYDirector
KIRK RANDAL J10% owner
KORNBLUTH ARTHUR ASHERDirector
Krumeich Karen RSVP and CFO
KUO JAMES SDirector
Lapointe Gregg AnthonyDirector
Madison T JDirector
Mintz Hal10% owner
MYRIANTHOPOULOS EVANDirector
MYRIANTHOPOULOS EVANChief Financial Officer
Parks Diane L.Director
Pearson Mark E.Director
Pearson Mark E.10% owner
Robertson George AVP Research & Development
ROSENWALD LINDSAY A MD10% owner
Rubin Robert JosephDirector
Salomon PeterDirector
Salomon PeterScientific Advisory Board
SALOMON PETER MDDirector
SCHABER CHRISTOPHERDirector
SCHABER CHRISTOPHERCHAIRMAN, CEO AND PRESIDENT
SCHNITTKER CHRISTOPHER PVP-Admin., Controller
SEDLACK STUART DDirector
SEMBER MICHAEL TDirector
SEMBER MICHAEL TChief Executive Officer
Sigma-Tau America S.A.10% owner
SIGMA TAU FINANZIARIA SPAFormer 10% Owner
SIGMA TAU FINANZIARIA SPA10% owner
SIGMA TAU INTERNATIONAL SA10% owner
Sigma-Tau Pharmaceuticals, Inc.Former 10% Owner
Sigma-Tau Pharmaceuticals, Inc.10% owner
Straube RichardCMO (Consulting)
THOMPSON VIRGILDirector
Warusz Joseph MichaelVP of Finance/Acting CFO
ZELDIS JEROME BDirector

Insider	Filed	Type	Qty	Price	Value · USD	Src
Straube Richard	Dec 12, 2025	AwardD	10,000	0.00 USD	$0	SEC
Donini Oreola	Dec 12, 2025	AwardD	100,000	0.00 USD	$0	SEC
Guarino Jonathan L.	Dec 12, 2025	AwardD	100,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Dec 12, 2025	AwardD	200,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Oct 3, 2025	Buy	15,132	1.32 USD	$20K	SEC
Rubin Robert Joseph	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
ZELDIS JEROME B	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
Parks Diane L.	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
Lapointe Gregg Anthony	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
Straube Richard	Dec 13, 2024	AwardD	12,000	0.00 USD	$0	SEC
Parks Diane L.	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Lapointe Gregg Anthony	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Rubin Robert Joseph	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Donini Oreola	Dec 13, 2024	AwardD	20,000	0.00 USD	$0	SEC
ZELDIS JEROME B	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Guarino Jonathan L.	Dec 13, 2024	AwardD	20,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Dec 13, 2024	AwardD	45,000	0.00 USD	$0	SEC
ZELDIS JEROME B	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Lapointe Gregg Anthony	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Rubin Robert Joseph	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Parks Diane L.	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Donini Oreola	Dec 8, 2023	AwardD	90,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Dec 8, 2023	AwardD	150,000	0.00 USD	$0	SEC
Guarino Jonathan L.	Dec 8, 2023	AwardD	90,000	0.00 USD	$0	SEC
Straube Richard	Dec 8, 2023	AwardD	75,000	0.00 USD	$0	SEC

Insider	Filed	Type	Qty	Price	Value · USD	Src
Straube Richard	Dec 12, 2025	AwardD	10,000	0.00 USD	$0	SEC
Donini Oreola	Dec 12, 2025	AwardD	100,000	0.00 USD	$0	SEC
Guarino Jonathan L.	Dec 12, 2025	AwardD	100,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Dec 12, 2025	AwardD	200,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Oct 3, 2025	Buy	15,132	1.32 USD	$20K	SEC
Rubin Robert Joseph	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
ZELDIS JEROME B	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
Parks Diane L.	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
Lapointe Gregg Anthony	Jun 20, 2025	AwardD	17,647	0.00 USD	$0	SEC
Straube Richard	Dec 13, 2024	AwardD	12,000	0.00 USD	$0	SEC
Parks Diane L.	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Lapointe Gregg Anthony	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Rubin Robert Joseph	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Donini Oreola	Dec 13, 2024	AwardD	20,000	0.00 USD	$0	SEC
ZELDIS JEROME B	Dec 13, 2024	AwardD	8,646	0.00 USD	$0	SEC
Guarino Jonathan L.	Dec 13, 2024	AwardD	20,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Dec 13, 2024	AwardD	45,000	0.00 USD	$0	SEC
ZELDIS JEROME B	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Lapointe Gregg Anthony	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Rubin Robert Joseph	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Parks Diane L.	Dec 15, 2023	AwardD	38,136	0.00 USD	$0	SEC
Donini Oreola	Dec 8, 2023	AwardD	90,000	0.00 USD	$0	SEC
SCHABER CHRISTOPHER	Dec 8, 2023	AwardD	150,000	0.00 USD	$0	SEC
Guarino Jonathan L.	Dec 8, 2023	AwardD	90,000	0.00 USD	$0	SEC
Straube Richard	Dec 8, 2023	AwardD	75,000	0.00 USD	$0	SEC

DOR BIOPHARMA INC

Insider trading at DOR BIOPHARMA INC

Current insiders at DOR BIOPHARMA INC

DOR BIOPHARMA INC

Insider trading at DOR BIOPHARMA INC

Current insiders at DOR BIOPHARMA INC

Insider transaction history at DOR BIOPHARMA INC

Insider transaction history at DOR BIOPHARMA INC